Genmab A/S (GMAB) reported a profit for its third quarter that Increased, from last year
The company's bottom line totaled $401 million, or $6.46 per share. This compares with $186 million, or $2.92 per share, last year.
The company's revenue for the period rose 25.2% to $1.022 billion from $0.816 billion last year.
Genmab A/S earnings at a glance (GAAP) :
-Earnings: $401 Mln. vs. $186 Mln. last year.-EPS: $6.46 vs. $2.92 last year.-Revenue: $1.022 Bln vs. $0.816 Bln last year.
-Guidance:Full year revenue guidance: $3.5 - $3.7 Bln
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.